All terms in EFO
| Label | Id | Description |
|---|---|---|
| nt-3 growth factor receptor measurement | EFO_0020613 | [The determination of the amount of nt-3 growth factor receptor in a sample] |
| nuclear receptor subfamily 1 group d member 1 measurement | EFO_0020614 | [The determination of the amount of nuclear receptor subfamily 1 group d member 1 in a sample] |
| pleiotrophin measurement | EFO_0020651 | [The determination of the amount of pleiotrophin in a sample] |
| prefoldin subunit 5 measurement | EFO_0020652 | [The determination of the amount of prefoldin subunit 5 in a sample] |
| probable g-protein coupled receptor 114 measurement | EFO_0020653 | [The determination of the amount of probable g-protein coupled receptor 114 in a sample] |
| programmed cell death 1 ligand 1 measurement | EFO_0020654 | [The determination of the amount of programmed cell death 1 ligand 1 in a sample] |
| platelet-derived growth factor subunit b measurement | EFO_0020650 | [The determination of the amount of platelet-derived growth factor subunit b in a sample] |
| Crotalus atrox | NCBITaxon_8730 | |
| gait measurement | EFO_0007680 | [quantification of some aspect of a person's gait such as rhythm, variability or step length] |
| aorta endothelium | UBERON_0004851 | [The thin layer of flat cells that line the aorta and form a barrier between circulating blood in the lumen and the rest of the vessel wall.] |
| streptozotocin | CHEBI_9288 | [An antibiotic that is produced by Streptomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals., A N-acylglucosamine that has formula C8H15N3O7.] |
| collection longitude | EFO_0005021 | [The longitude at which a sample was obtained. For example a sea water sample.] |
| response to high fat food intake | EFO_0007684 | [physiological response of an organism, eg in terms of blood lipid levels, to the ingestition of high fat food] |
| response to CAPOX-B | EFO_0007683 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus with a combination of the chemotherapy drugs capecitabine, oxaliplatin and bevacizumab, known as the CAPOX-B cocktail] |
| obsolete_autosomal dominant palmoplantar keratoderma and congenital alopecia | Orphanet_1010 | |
| response to cetuximab | EFO_0007682 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus with the epithelial growth factor inhibitor cetuximab.] |
| collection latitude | EFO_0005020 | [The latitude at which a sample was obtained. For example a sea water sample.] |
| triglyceride change measurement | EFO_0007681 | [quantification of the change in triglyceride levels in an individual over time, eg over the course of several hours after a high-fat meal ] |
| microRNA profiling by RT-PCR | EFO_0007687 | [An assay in which a set of microRNAs of a biological sample is analysed by reverse transcription PCR (RT-PCR)] |
| surgical shock | EFO_0007686 | [A type of shock that occurs as a result of a surgical procedure.] |